scholarly article | Q13442814 |
P356 | DOI | 10.1001/ARCHDERM.1961.01580150005001 |
P698 | PubMed publication ID | 13778561 |
P2093 | author name string | R K WINKELMANN | |
D L TUFFANELLI | |||
P921 | main subject | systemic scleroderma | Q5340515 |
P304 | page(s) | 359-371 | |
P577 | publication date | 1961-09-01 | |
P1433 | published in | Archives of Dermatology | Q15749524 |
P1476 | title | Systemic scleroderma, A clinical study of 727 cases | |
P478 | volume | 84 |
Q41731448 | Absence of oesophageal mucosal folds in systemic sclerosis |
Q35143907 | Acute Scleroderma (morphoea) with Myositis |
Q71097853 | Anaemia due to blood loss from the telangiectases of scleroderma |
Q35117202 | Assessment of esophageal involvement in systemic sclerosis and morphea (localized scleroderma) by clinical, endoscopic, manometric and pH metric features: a prospective comparative hospital based study. |
Q34236081 | Autoantibodies and overlap syndromes in autoimmune rheumatic disease |
Q71557922 | Autoantibodies to the heat-shock protein hsp73 in localized scleroderma |
Q47925692 | Autoimmune Haemolytic Anaemia with Positive Ham and Crosby's Test and Scleroderma: A Case Report |
Q69779323 | Avascular necrosis of the femoral head in long-term follow-up of systemic sclerosis: report of two cases |
Q76677074 | CHRONIC DISEASE OF THE LIVER ASSOCIATED WITH SYSTEMIC SCLERODERMA |
Q35896510 | CURRENT CONCEPTS IN DERMATOLOGY. II. THE SKIN AND SYSTEMIC DISEASE |
Q35437082 | CURRENT CONCEPTS OF THE PATHOGENESIS OF THE SO-CALLED COLLAGEN DISEASES. |
Q42006360 | Case of mixed connective tissue disease associated with autoimmune hepatitis |
Q41122085 | Central retinal vein occlusion and scleroderma: implications for sclerodermatous vascular disease |
Q34152922 | Characterization of monocyte/macrophage subsets in the skin and peripheral blood derived from patients with systemic sclerosis |
Q40697280 | Classification of scleroderma |
Q72196962 | Clinical characteristics associated with antihistone antibodies in patients with localized scleroderma |
Q67472028 | Clinical evaluation of scleroderma spectrum disorders using a points system |
Q70232740 | Clinical profiles of patients with antibodies to nuclear ribonucleoprotein |
Q33551496 | Clinical significance of antibodies to soluble extractable nuclear antigens (anti-ENA) |
Q85023043 | Close association of anti-U1 ribonucleoprotein antibody with drug allergy in patients with connective tissue diseases |
Q72554756 | Color Changes in the Extremities as They Relate to Peripheral Vascular Disease |
Q40611361 | Condylysis in a patient with a mixed collagen vascular disease |
Q71821906 | Connective tissue diseases |
Q37594898 | Connective tissue ulcers |
Q72130260 | Current concepts in the classification of connective tissue diseases. Overlap syndromes and mixed connective tissue disease (MCTD) |
Q72268809 | Cutaneous Manifestations of Gastrointestinal Disease |
Q72788575 | Cutaneous signs (Raynaud's phenomenon, sclerodactylia, and edema of the hands) and hand-arm vibration exposure |
Q72269085 | Demonstration of interleukin-2, interleukin-4 and interleukin-6 in sera from patients with localized scleroderma |
Q33570128 | Development of connective tissue disease in patients presenting with Raynaud's phenomenon: a six year follow up with emphasis on the predictive value of antinuclear antibodies as detected by immunoblotting |
Q72230312 | Diffuse systemic sclerosis with abnormal liver and gall bladder |
Q49159854 | Efficacy of connective tissue massage and Mc Mennell joint manipulation in the rehabilitative treatment of the hands in systemic sclerosis |
Q71267975 | Electrocardiographic examination in patients with skin diseases |
Q39476745 | Electrophysiological evidence of "nerve entrapment syndromes" and subclinical peripheral neuropathy in progressive systemic sclerosis (scleroderma). |
Q40031365 | Entero-arthropathy: The Coexistence of Articular and Gastrointestinal Manifestations in Systemic Disease |
Q29036024 | Eosinophilic fasciitis. Case report and review of the literature |
Q33631736 | Epidemiology of scleroderma |
Q71448553 | Esophageal Motility |
Q35687801 | Esophageal involvement in scleroderma: clinical, endoscopic, and manometric features |
Q55982204 | Frequency, levels, and significance of blood eosinophilia in systemic sclerosis, localized scleroderma, and eosinophilic fasciitis |
Q42739520 | GENERALIZED MORPHOEA. |
Q39115954 | Gastroesophageal Reflux in Esophageal Scleroderma: Diagnosis and Implications |
Q73364623 | HLA‐B8 in Raynaud's Phenomenon |
Q35553844 | Hepatic manifestations of autoimmune rheumatic diseases |
Q39822728 | Hepatocyte giant mitochondria: An almost constant lesion in systemic scleroderma |
Q71006450 | Hereditary hemorrhagic telangiectasia versus CREST syndrome: can serology aid diagnosis? |
Q73520766 | Idiopathic inflammatory myopathies |
Q39830587 | Immune complex nephropathy in mixed connective tissue disease |
Q48587777 | Impaired quantitative cerebral blood flow in scleroderma patients |
Q34493242 | Increased C1q binding and arthritis in primary biliary cirrhosis |
Q34374484 | Juvenile systemic scleroderma |
Q67599142 | Long-term follow-up study of 164 patients with definite systemic sclerosis: classification considerations |
Q40528990 | Lymphokine stimulation of collagen accumulation |
Q39351914 | Management of sclerodermal finger ulcers |
Q39859237 | Membranoproliferative glomerulonephritis in systemic sclerosis of childhood |
Q47660081 | Microvascular involvement in Systemic Sclerosis and Systemic Lupus Erythematosus. |
Q69388522 | Mixed connective tissue disease |
Q33631754 | Mixed connective tissue disease, overlap syndromes, and eosinophilic fasciitis |
Q36376858 | Morbidity and mortality of patients diagnosed with systemic sclerosis after the age of 75: a nested case-control study |
Q51551268 | Multiple avascular necrosis in a patient with systemic lupus erythematosus/systemic sclerosis overlap syndrome. |
Q34407876 | Muscle abnormalities in scleroderma |
Q46256178 | Muscle involvement in systemic sclerosis: points to consider in clinical trials |
Q84850103 | Necrotizing fasciitis in a patient with overlap syndrome of systemic sclerosis and systemic lupus erythematosus |
Q39644827 | Neoplastic associations of rheumatic diseases and rheumatic manifestations of cancer. |
Q37879776 | Neurological complications of systemic sclerosis--a report of three cases and review of the literature |
Q40207637 | Neuropsychiatric problems in mixed connective tissue disease |
Q41220150 | Occupational and environmental influences on scleroderma |
Q72255724 | Oesophageal motility in connective tissue disease |
Q72814441 | Oesophageal motility studies |
Q33995782 | Ophthalmic manifestations of progressive systemic sclerosis |
Q33579824 | Osteodysplasty (Melnick and Needles syndrome). Report of a case |
Q78229093 | PROGNOSIS IN RAYNAUD'S PHENOMENON AFTER SYMPATHECTOMY |
Q55315342 | Pancytopenia and scleroderma |
Q41069217 | Pathogenesis of systemic sclerosis: A vascular hypothesis |
Q39794476 | Penicillamine-induced rapidly progressive glomerulonephritis in patients with progressive systemic sclerosis: successful treatment of two patients and a review of the literature |
Q70168385 | Peripheral neuropathy in course of progressive systemic sclerosis. Light and ultrastructural study |
Q41628384 | Peripheral neuropathy in the course of progressive systemic sclerosis: light and ultrastructural study |
Q54507112 | Polymyositis associated with several immunological disorders. |
Q81841532 | Predictive value of nailfold capillaroscopy in patients with Raynaud's phenomenon |
Q42093945 | Prevalence and clinical relevance of 52-kDa and 60-kDa Ro/SS-A autoantibodies in Japanese patients with systemic sclerosis |
Q77676693 | Prevalence of impaired gastric emptying of solids in systemic sclerosis: diagnostic and therapeutic implications |
Q35603089 | Primary B-cell lymphoma of the tongue in a patient with systemic sclerosis |
Q35609106 | Primary biliary cirrhosis associated with systemic sclerosis: diagnostic and clinical challenges. |
Q33579829 | Prodromal trigeminal sensory neuropathy in progressive systemic sclerosis |
Q44274898 | Prognosis of generalized scleroderma. A retrospective study of 78 cases |
Q71456178 | Progressive Systemic Sclerosis (Scleroderma) |
Q41625669 | Proximal stomach and antrum in stomach emptying |
Q39530587 | Pyloric stenosis in a patient with progressive systemic sclerosis |
Q33356119 | RENAL VASCULAR DISEASE. |
Q34352783 | Race and association with disease manifestations and mortality in scleroderma: a 20-year experience at the Johns Hopkins Scleroderma Center and review of the literature. |
Q35637515 | Radiological hand involvement in systemic sclerosis |
Q70489439 | Raynaud's disease |
Q33631731 | Raynaud's phenomenon: its relevance to scleroderma |
Q34385471 | Recognition and management of scleroderma in children |
Q73335112 | Refractory Raynaud's phenomenon in scleroderma: an indication for surgery |
Q73024605 | Relationships between electrocardiographic and echocardiographic findings in systemic sclerosis (scleroderma) |
Q49375225 | Resolution of cutaneous manifestations of systemic sclerosis after haemodialysis |
Q33568738 | Respiratory function in systemic lupus erythematosus, scleroderma, and rheumatoid arthritis |
Q39552991 | Reverse transcriptase in a patient with scleroderma |
Q74571075 | Rheumatic diseases and malignancy--is there an association? |
Q40513147 | Rheumatoid arthritis and connective tissue disorders: India and South-East Asia |
Q66880580 | Scleroderma |
Q44530975 | Scleroderma (Progressive Systemic Sclerosis): progress and course based on a personal series of 118 cases |
Q33553581 | Scleroderma and erosive polyarthritis: a disease entity? |
Q33565616 | Scleroderma and malignancy: an epidemiological study |
Q72650201 | Scleroderma and motor neuron disease: an unusual association |
Q71371699 | Scleroderma and other diseases associated with cutaneous sclerosis |
Q56008640 | Scleroderma and primary biliary cirrhosis |
Q41333515 | Scleroderma and related conditions |
Q33563548 | Scleroderma and survival |
Q35939760 | Scleroderma and the kidney |
Q38020677 | Scleroderma esophagus |
Q35151855 | Scleroderma in childhood. Report of 5 cases |
Q70025625 | Scleroderma in the child |
Q71817226 | Scleroderma in the elderly, with special reference to the CRST syndrome |
Q33765558 | Scleroderma-polymyositis overlap syndrome versus idiopathic polymyositis and systemic sclerosis: a descriptive study on clinical features and myopathology |
Q67653673 | Sclerosis of the intestinal tract with severe malabsorption |
Q33722916 | Screening for cancer in the patient with rheumatic disease |
Q38070319 | Seizures in systemic sclerosis |
Q69590497 | Specificity and sensitivity of esophageal motor abnormality in systemic sclerosis (scleroderma) and related diseases: a cineradiographic study |
Q71015931 | Surgical management of scleroderma reflux esophagitis |
Q72104104 | Surgical presentation of systemic sclerosis of the small intestine |
Q40809160 | Survival and causes of death in systemic sclerosis patients: a single center registry report from Iran |
Q33567971 | Survival in scleroderma |
Q45337964 | Survival with scleroderma—II: A life-table analysis of clinical and demographic factors in 358 male U.S. veteran patients |
Q64974174 | Systemic lupus erythematosus: a report of forty-five cases with unusual clinical and immunological features |
Q41790524 | Systemic scleroderma and malignant diseases. A review of the literature |
Q35549272 | Systemic scleroderma in Greece: low mortality and strong linkage with HLA-DRB1*1104 allele. |
Q39634078 | Systemic scleroderma. Clinical and pathophysiologic aspects |
Q43858585 | Systemic sclerosis and cryoglobulinemia |
Q73181326 | Systemic sclerosis and scleroderma renal crisis in association with carcinoma of the breast |
Q35004032 | Systemic sclerosis and small bowel involvement |
Q33594498 | Systemic sclerosis associated with colliquative necrosis in the cerebellum |
Q33566531 | Systemic sclerosis in Iceland. A nationwide epidemiological study |
Q57651740 | Systemic sclerosis in old age |
Q67992439 | Systemic sclerosis in the elderly |
Q42020247 | Systemic sclerosis sine scleroderma presenting with vitiligo-like depigmentation and interstitial pulmonary fibrosis |
Q35898408 | Telangiectases simulating hereditary hemorrhagic telangiectasia in scleroderma. Report of two cases |
Q36771906 | The Raynaud syndrome |
Q39932900 | The Rheumatic Diseases in Adolescence |
Q33551584 | The arthritis of mixed connective tissue disease |
Q33553587 | The articular manifestations of progressive systemic sclerosis (scleroderma). |
Q36722268 | The diagnosis and classification of scleroderma (systemic sclerosis) |
Q40697329 | The diagnosis of Raynaud's phenomenon |
Q41220252 | The nervous system in systemic sclerosis (scleroderma). Clinical features and pathogenetic mechanisms |
Q35897751 | The pathogenesis of esophageal dysfunction in scleroderma and Raynaud's disease |
Q39941874 | The rheumatic diseases of childhood |
Q44448148 | The significance of an air oesophagogram visualised on conventional chest radiographs |
Q70786234 | The skin changes in scleroderma (systemic sclerosis) |
Q43739773 | The systemic involvement in scleroderma |
Q35309080 | Towards systemic sclerosis and away from primary biliary cirrhosis: the case of PTPN22. |
Q69700736 | Treatment of scleroderma skin ulcers with a hydrocolloid membrane |
Q67863951 | Trigeminal sensory-neuropathy in systemic sclerosis |
Q76562423 | URINARY 5-HYDROXYINDOLEACETIC ACID EXCRETION IN SCLERODERMA |
Q94325515 | Ultraviolet autorepigmentation in scleroderma |
Q44901834 | Unusual case of progressive systemic sclerosis with onset in early childhood and following infectious mononucleosis |
Q36806259 | Vascular leak is a central feature in the pathogenesis of systemic sclerosis |
Q80052072 | [Autoimmune hepatitis and morphea: a rare association] |
Q78046768 | [Involvement of the small intestine in systemic scleroderma] |
Q79601482 | [Peculiarities in progressive scleroderma] |
Q73245714 | [Pulmonary involvement in systemic scleroderma. Part I. Chronic fibrosing interstitial lung disease] |
Search more.